Pneulyfe is a start-up nutraceutical company that seeks to provide a natural alternative for respiratory illnesses such as pneumonia, asthma, influenza and bronchitis. Pneulyfe is a treatment that addresses this issue and fits what customers want- an all-natural product that is effective and does not present adverse side effects instead of traditional pharmaceuticals commonly used. Pneulyfe is looking to expand their business market and income potential over the next five years. Part of this success will be the securing grant funds. This increase in capital will allow Pneulyfe to expand their work force and marketing starting in 2019. Pneulyfe was formed in 2017. The idea for Pneulyfe originated through Monique Brown-Johnson’s (founder) experience with pneumonia. Her experience was characterized by excruciating pain and medications that were ineffective and caused adverse sides effects which she did not want anyone else to encounter.